Revenue (Tables)

6 Months Ended

Jun. 30, 2019

Disaggregation of Revenue [Abstract]

Disaggregation of Revenue [Table Text Block]

The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions):

	Three Months Ended June 30,				Six Months Ended June 30,
Businesses	2019		2018		2019		2018
Endoscopy
U.S.	$	270	$	245	$	523	$	477
International	200		197		387		384
Worldwide	470		442		910		861
Urology and Pelvic Health
U.S.	248		213		479		409
International	100		96		195		192
Worldwide	348		308		674		601
Cardiac Rhythm Management
U.S.	288		290		576		580
International	210		204		413		407
Worldwide	498		494		989		987
Electrophysiology
U.S.	39		39		75		74
International	46		40		89		79
Worldwide	84		79		164		154
Neuromodulation
U.S.	160		160		304		291
International	44		42		86		79
Worldwide	204		202		390		371
Interventional Cardiology
U.S.	318		296		614		577
International	388		366		753		730
Worldwide	706		662		1,367		1,307
Peripheral Interventions
U.S.	155		152		311		297
International	165		152		320		294
Worldwide	320		304		631		591
Total Company
U.S.	1,478		1,394		2,881		2,704
International	1,153		1,096		2,243		2,166
Net Sales	$	2,631	$	2,490	$	5,124	$	4,870

	Three Months Ended June 30,				Six Months Ended June 30,
Geographic Regions	2019		2018		2019		2018
U.S.	$	1,478	$	1,394	$	2,881	$	2,704
EMEA (Europe, Middle East and Africa)	571		558		1,132		1,121
APAC (Asia-Pacific)	481		442		918		857
Latin America and Canada	101		96		192		188
	$	2,631	$	2,490	$	5,124	$	4,870
Emerging Markets†	$	318	$	283	$	614	$	545

^†